Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors
- 1 July 1997
- journal article
- clinical trial
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 29 (1) , 28-32
- https://doi.org/10.1002/(sici)1096-911x(199707)29:1<28::aid-mpo5>3.0.co;2-u
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-upCancer, 1995
- Phase I study of oral etoposide in children with refractory solid tumors.Journal of Clinical Oncology, 1994
- Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood.Journal of Clinical Oncology, 1993
- Bioavailability of low-dose oral etoposide.Journal of Clinical Oncology, 1993
- Recurrent brainstem gliomas treated with oral VP-16Journal of Neuro-Oncology, 1993
- Cell death induced by topoisomerase inhibitors: Role of calcium in mammalian cellsBiochemical Pharmacology, 1991
- Biochemical characteristics and physiological significance of major DNA topoisomerasesAntimicrobial Agents and Chemotherapy, 1989
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Mechanism of Action of Antitumor Drug Etoposide: A ReviewJNCI Journal of the National Cancer Institute, 1988
- Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cellsBiochemistry, 1976